Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells
de la Taille A;Rubin MA;Chen MW;Vacherot F;de Medina SG;Burchardt M;Buttyan R;Chopin D;;
clinical cancer research : an official journal of the american association for cancer research2003Vol. 9pp. -
294
a2003clinicalbeta-catenin-related
Abstract
These data suggest that anomalies of beta-catenin expression occur in PrCa and that these anomalies are associated with disease progression, especially to the therapeutic-resistant state.